Comparison of Hyperemic Efficacy Between Nicorandil and Adenosine for Fractional Flow Reserve (FFR) Measurement
Phase 4
- Conditions
- Coronary Artery DiseaseMyocardial Ischemia
- Interventions
- Other: Maximal Hyperemia with Adenosine Followed by NicorandilOther: Maximal Hyperemia with Nicorandil Followed by Adenosine
- Registration Number
- NCT01331902
- Lead Sponsor
- Seoul National University Hospital
- Brief Summary
The purpose of this study is to evaluate the efficacy of nicorandil in the achievement of maximal coronary hyperemia compared with adenosine.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 200
Inclusion Criteria
- non -infarct related, patients with moderate coronary artery stenosis
- normal left ventricular ejection fraction on echocardiogram
Exclusion Criteria
- infarct-related arteries or clinically unstable state
- collateral blood flow to the target vessel is shown
- atrioventricular block on electrocardiogram
- reduced left ventricular ejection fraction (<50%) or left ventricular hypertrophy on echocardiogram
- contraindication of adenosine
- bronchial asthma
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- CROSSOVER
- Arm && Interventions
Group Intervention Description Adenosine Followed by Nicorandil Maximal Hyperemia with Adenosine Followed by Nicorandil - Nicorandil Followed by Adenosine Maximal Hyperemia with Nicorandil Followed by Adenosine -
- Primary Outcome Measures
Name Time Method Fractional Flow Reserve at Maximal Hyperemia 1 day
- Secondary Outcome Measures
Name Time Method Time to Maximal Hyperemia 1 day Changes in Heart Rate 1 day
Trial Locations
- Locations (1)
Cardiovascular Center, Seoul National University Hospital
🇰🇷Seoul, Korea, Republic of